Header Logo

Connection

Srinivas Vourganti to Prostatic Neoplasms

Back to Details
This is a "connection" page, showing publications Srinivas Vourganti has written about Prostatic Neoplasms.
Srinivas Vourganti
Connection Strength
6.450
Prostatic Neoplasms
  1. Pro: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate Cancer. J Urol. 2022 08; 208(2):246-247.
    View in: PubMed
    Score: 0.757
  2. Outcomes of freehand transperineal prostate biopsy with omission of antibiotic prophylaxis. BJU Int. 2022 07; 130(1):54-61.
    View in: PubMed
    Score: 0.737
  3. Assessing the diagnostic performance of systematic freehand PrecisionPoint transperineal prostate biopsy: Comparison of observed outcomes to PBCG nomogram predictions. Urol Oncol. 2022 01; 40(1):4.e9-4.e17.
    View in: PubMed
    Score: 0.729
  4. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning. Curr Urol Rep. 2017 Oct 18; 18(12):93.
    View in: PubMed
    Score: 0.552
  5. MR/US Fusion Technology: What Makes It Tick? Curr Urol Rep. 2017 Mar; 18(3):20.
    View in: PubMed
    Score: 0.528
  6. Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers. Prostate. 2016 09; 76(13):1135-45.
    View in: PubMed
    Score: 0.501
  7. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. 2012 Dec; 188(6):2152-2157.
    View in: PubMed
    Score: 0.390
  8. Single-Port Robot-Assisted Radical Prostatectomy: Where Do We Stand? Curr Oncol. 2023 04 20; 30(4):4301-4310.
    View in: PubMed
    Score: 0.202
  9. Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol. 2022 08 01; 8(8):1128-1136.
    View in: PubMed
    Score: 0.192
  10. Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions. Cancer. 2022 09 15; 128(18):3287-3296.
    View in: PubMed
    Score: 0.191
  11. Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. Eur Urol. 2021 09; 80(3):386.
    View in: PubMed
    Score: 0.177
  12. Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World J Urol. 2021 Mar; 39(3):677-686.
    View in: PubMed
    Score: 0.167
  13. Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
    View in: PubMed
    Score: 0.143
  14. Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells. J Urol. 2016 Apr; 195(4 Pt 1):1136-42.
    View in: PubMed
    Score: 0.121
  15. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int. 2015 Mar; 115(3):381-8.
    View in: PubMed
    Score: 0.111
  16. Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol. 2014 Jul-Aug; 20(4):293-8.
    View in: PubMed
    Score: 0.110
  17. Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol. 2014 May-Jun; 20(3):234-8.
    View in: PubMed
    Score: 0.108
  18. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer. 2013 Sep 15; 119(18):3359-66.
    View in: PubMed
    Score: 0.102
  19. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol. 2013 Dec; 190(6):2020-2025.
    View in: PubMed
    Score: 0.102
  20. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013 Nov; 64(5):713-719.
    View in: PubMed
    Score: 0.102
  21. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol. 2013 Nov; 190(5):1721-1727.
    View in: PubMed
    Score: 0.102
  22. Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int. 2012 Dec; 110(11 Pt B):E783-8.
    View in: PubMed
    Score: 0.098
  23. Image guidance in the focal treatment of prostate cancer. Curr Opin Urol. 2012 Jul; 22(4):328-35.
    View in: PubMed
    Score: 0.096
  24. Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples. Urology. 2011 Sep; 78(3):601-5.
    View in: PubMed
    Score: 0.090
  25. Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy Workshop. Urology. 2019 Dec; 134:51-55.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.